Healthcare / Medical Care FacilitiesHKSE
$0.07
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-42.2M · quality 72.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
13/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$406M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-6.1%
↓Gross Margin
27.0%
↓Debt/Equity
0.07
↓Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
-6.3%
FCF CAGR
—
FCF margin
-21.6%
FCF / Net income
0.34x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $157.2M · net income $-100.9M · FCF $-34.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | $157.2M | $157.2M | $149.9M | $140.3M | $166.5M | $203.8M |
| Net Income | $-100.9M | $-100.9M | $-116.2M | $-61.9M | $-97.7M | $-39.4M |
| EBITDA | $-78.3M | $-78.3M | $-97.5M | $-44.2M | $-75.2M | $-10.4M |
| EPS | — | — | -0.02 | -0.01 | -0.02 | -0.01 |
| Gross Margin | 27.0% | 27.0% | 23.8% | 27.4% | 27.9% | 23.1% |
| Operating Margin | -33.5% | -33.5% | -38.8% | -45.1% | -39.2% | -42.1% |
| Net Margin | -64.2% | -64.2% | -77.5% | -44.1% | -58.7% | -19.3% |
| Balance Sheet | ||||||
| Debt/Equity | 0.07 | 0.07 | 0.00 | 0.00 | 0.02 | 0.02 |
| Current Ratio | 1.26 | 1.26 | — | — | — | — |
| Cash Flow | ||||||
| Free Cash Flow | $-34.0M | $-34.0M | $-42.2M | $-45.1M | $-34.4M | $-22.8M |
| Returns | ||||||
| ROE | -6.1% | -6.1% | -6.8% | -3.3% | -4.8% | -1.7% |
| Valuation | ||||||
| P/B | 0.24 | 0.24 | 0.27 | 0.21 | 0.20 | 0.24 |
| Growth & Yield | ||||||
| Revenue Growth | 4.8% | 4.8% | 6.8% | -15.7% | — | — |
| EPS Growth | — | — | -90.1% | 37.3% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.